MAOA, DBH, and SLC6A4 variants in CHARGE: A case-control study of autism spectrum disorders

Autism Research

Volumn 4, Issue 4, 2011, Pages 250-261

  Tassone, Flora ^a,b   Qi, Lihong ^a,b   Zhang, Wenting ^a   Hansen, Robin L ^a,b   Pessah, Isaac N ^b,c   Hertz Picciotto, Irva ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ASD; DBH; MAOA; Polymorphisms; SLC6A4

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE BETA MONOOXYGENASE; SEROTONIN TRANSPORTER;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; TANDEM REPEAT;

ALLELES; CASE-CONTROL STUDIES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DOPAMINE BETA-HYDROXYLASE; ENVIRONMENT; FATHERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MONOAMINE OXIDASE; MOTHERS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS;

EID: 80055039885     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.196     Document Type: Article

References (84)

1. Anderson, G.M., Horne, W.C., Chatterjee, D., & Cohen, D.J. (1990). The hyperserotonemia of autism. Annals of the New York Academy of Sciences, 600, 331-340, discussion 341-342.
2. Anderson, G.M. (2002). Genetics of childhood disorders: XLV. Autism, part 4: Serotonin in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1513-1516.
3. Anderson, G.M., Freedman, D.X., Cohen, D.J., Volkmar, F.R., Hoder, E.L., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885-900.
4. Anderson, G.M., Gutknecht, L., Cohen, D.J., Brailly-Tabard, S., Cohen, J.H.M., et al. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7, 831-836.
5. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Investigators. (2007). Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56, 12-28.
6. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., et al. (1995). Autism as a strongly genetic disorder: Evidence from a British twin study. Psychological Medicine, 25, 63.
7. Bartlett, C.W., Gharani, N., Millonig, J.H., & Brzustowicz, L.M. (2005). Three autism candidate genes: A synthesis of human genetic analysis with other disciplines. International Journal of Developmental Neuroscience, 23, 221-234.
8. Bill, B.R., & Geschwind, D.H. (2009). Genetic advances in autism: Heterogeneity and convergence on shared pathways. Current Opinion in Genetics & Development, 19, 271-278.
9. Buckholtz, J.W., & Meyer-Lindenberg, A. (2008). MAOA and the neurogenetic architecture of human aggression. Trends in Neurosciences, 31, 120-129.
10. Buxbaum, J.D. (2009). Multiple rare variants in the etiology of autism spectrum disorders. Dialogues in Clinical Neurosciences, 11, 35-43.
11. Cases, O., Vitalis, T., Seif, I., De Maeyer, E., Sotelo, C., & Gaspar, P. (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase a-deficient mice: Role of a serotonin excess during the critical period. Neuron, 16, 297-307.
12. Cohen, I., Liu, X., Lewis, M., Chudley, A., Forster-Gibson, C., et al. (2010). Autism severity is associated with child and maternal MAOA genotypes. Clinical Genetics, 79, 355-362.
13. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., et al. (2003). Association of autism severity with a monoamine oxidase A functional polymorphism. Clinical Genetics, 64, 190.
14. Cook, Jr., E.H. (1990). Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. The Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268-274.
15. Cook, E.H., & Leventhal, B.L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348-354.
16. Cook, E.H., Courchesne, R., Lord, C., Cox, N.J., Yan, S., et al. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2, 247-250.
17. Cubells, J.F., Kranzler, H.R., McCance-Katz, E., Anderson, G.M., Malison, R.T., et al. (2000). A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Molecular Psychiatry, 5, 56-63.
18. D'Souzav U.M., & Craig, I.W. (2008). Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Progress in Brain Research, 172, 73-98.
19. Deckert, J., Catalano, M., Syagailo, Y.V., Bosi, M., Okladnova, O., et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics, 8, 621-624.
20. Denney, R.M., Koch, H., & Craig, I.W. (1999). Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Human Genetics, 105, 542-551.
21. Devlin, B., Cook, E.H., Coon, H., Dawson, G., Grigorenko, E.L., et al. (2005). Autism and the serotonin transporter: The long and short of it. Molecular Psychiatry, 10, 1110.
22. Filic, V., Vladic, A., Stefulj, J., Cicin-Sain, L., Balija, M., et al. (2005). Monoamine oxidases A and B gene polymorphisms in migraine patients. Journal of the Neurological Sciences, 228, 149-153.
23. Fombonne, E. (2003). The Prevalence of Autism. American Medical Association 87-89.
24. Freitag, C.M. (2007). The genetics of autistic disorders and its clinical relevance: A review of the literature. Molecular Psychiatry, 12, 2-22.
25. Freitag, C.M., Staal, W., Klauck, S.M., Duketis, E., & Waltes, R. (2010). Genetics of autistic disorders: Review and clinical implications. European Child & Adolescent Psychiatry, 19, 169-178.
26. Gaspar, P., Cases, O., & Maroteaux, L. (2003). The developmental role of serotonin: News from mouse molecular genetics. Nature Reviews. Neuroscience, 4, 1002-1012.
27. Gillberg, C., & Coleman, M. (2000). The biology of the autistic syndromes. London: MacKeith Press.
28. Gilman, J., & Tuchman, R.F. (1995). Autism and associated behavioral disorders: Pharmacotherapeutic intervention. The Annals of Pharmacotherapy, 29, 47-56.
29. Glessner, J.T., Wang, K., Cai, G., Korvatska, O., Kim, C.E., Wood, S., et al. (2009). Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459, 569-573.
30. Goldberg, W.A., Osann, K., Filipek, P.A., Laulhere, T., Jarvis, K., et al. (2003). Language and other regression: Assessment and timing. Journal of Autism and Development Disorders, 33, 607-616.
31. Gordon, C.T., State, R.C., Nelson, J.E., Hamburger, S.D., & Rapoport, J.L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441-447.
32. Guhathakurta, S., Ghosh, S., Sinha, S., Chatterjee, A., Ahmed, S., et al. (2006). Serotonin transporter promoter variants: Analysis in Indian autistic and control population. Brain Research, 1092, 28-35.
33. Hallett, V., Ronald, A., Rijsdijk, F., & Happe, F. (2010). Association of autistic-like and internalizing traits during childhood: A longitudinal twin study. American Journal of Psychiatry, 167, 809-817.
34. Hansen, R.L., Ozonoff, S., Krakowiak, P., Angkustsiri, K., Jones, C., et al. (2008). Regression in autism: Prevalence and associated factors in the CHARGE Study. Ambulatory Pediatrics, 8, 25-31.
35. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., et al. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66, 2621.
36. Hellings, J.A., Kelley, L.A., Gabrielli, W.F., Kilgore, E., & Shah, P. (1996). Sertraline response in adults with mental retardation and autistic disorder. Journal of Clinical Psychiatry, 57, 333-336.
37. Hertz-Picciotto, I., Croen, L.A., Hansen, R., Jones, C.R., van de Water, J., & Pessah, I.N. (2006). The CHARGE Study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives, 114, 1119.
38. Hertz-Picciotto, I. (2011). Environmental risk factors in autism: Results from large-scale epidemiology studies. In: Amaral, D., Geschwind, D., Dawson, G., editors. Autism Spectrum Disorders. New York: Oxford University Press.
39. Hranilovic, D., Novak, R., Babic, M., Novokmet, M., Bujas-Petkovic, Z., & Jernej, B. (2008). Hyperserotonemia in autism: The potential role of 5HT-related gene variants. Collegium antropologicum, 32, 75.
40. Jones, M.B., Palmour, R.M., Zwaigenbaum, L., & Szatmari, P. (2004). Modifier effects in autism at the MAO-A and DBH loci. American Journal of Medical Genetics Part B, 126, 58-65.
41. Klauck, S.M. (1997). Serotonin transporter (5-HTT) gene variants associated with autism? Human Molecular Genetics, 6, 2233-2238.
42. Lake, C.R., Ziegler, M.G., & Murphy, D.L. (1977). Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Archives of General Psychiatry, 34, 553-556.
43. Lamb, J.A., Moore, J., Bailey, A., & Monaco, A.P. (2000). Autism: Recent molecular genetic advances. Oxford: Oxford University Press, pp 861-868.
44. Lee, S.Y., Hahn, C.Y., Lee, J.F., Chen, S.L., Chen, S.H., et al. (2009). MAOA-uVNTR polymorphism may modify the protective effect of ALDH2 gene against alcohol dependence in antisocial personality disorder. Alcoholism: Clinical and Experimental Research, 33, 985-990.
45. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527.
46. Lichtenstein, P., Carlstrom, E., Rastam, M., Gillberg, C., & Anckarsater, H. (2010). The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. American Journal of Psychiatry, 167, 1357-1363.
47. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685.
48. Lord, C., Risi, S., Lambrecht, L., Cook, E.H., Leventhal, B.L., et al. (2000). The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205-223.
49. Ma, D., Salyakina, D., Jaworski, J.M., Konidari, I., Whitehead, P.L., et al. (2009). A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Annals of Human Genetics, 73, 263-273.
50. Maestrini, E., Lai, C., Marlow, A., Matthews, N., & Wallace, S. (1999). Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta 3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. American Journal of Medical Genetics, 88, 492-496.
51. Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics, 82, 477-488.
52. May, M.E., Srour, A., Hedges, L.K., Lightfoot, D.A., Phillips, J.A., et al. (2009). Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. American Journal of Intellectual and Developmental Disabilities, 114, 269-273.
53. McDougle, C.J., Naylor, S.T., Cohen, D.J., Aghajanian, G.K., Heninger, G.R., & Price, L.H. (1996). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993-1000.
54. Muhle, R., Trentacoste, S.V., & Rapin, I. (2004). The Genetics of Autism. Pediatrics, 113, 472-486.
55. Mullen, E.M. (1995). Mullen Scales of Early Learning. Circle Pines: American Guidance Services, Inc.
56. Nordquist, N., & Oreland, L. (2010). Serotonin, genetic variability, behaviour, and psychiatric disorders-a review. Upsala Journal of Medical Sciences, 115, 2-10.
57. ® augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 12, 165-171.
58. Ozonoff, S., Iosif, A.M., Baguio, F., Cook, I.C., Hill, M.M., et al. (2010). A prospective study of the emergence of early behavioral signs of autism. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 256-266 e1-2.
59. Persico, A.M., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., et al. (2000). Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. American Journal of Medical Genetics, 96, 123-127.
60. Pessah, I.N., & Lein, P.J. (2008). Evidence of environmental susceptibility in autism. In: Zimmerman, A.W., editor. Autism. Totowa: Humana Press. pp 409-428.
61. Pigott, T.A., & Seay, S.M. (1999). A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. The Journal of clinical psychiatry, 60, 101-106.
62. Piven, J., Tsai, G.C., Nehme, E., Coyle, J.T., Chase, G.A., & Folstein, S.E. (1991). Platelet serotonin, a possible marker for familial autism. The Journal of Autism and Developmental Disorders, 21, 51-59.
63. Ramoz, N., Reichert, J.G., Corwin, T.E., Smith, C.J., Silverman, J.M., et al. (2006). Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biological Psychiatry, 60, 186-191.
64. Rao, G.V., & Rao, K.S. (1993). Inhibition of monoamine oxidase-A of rat brain by pyrethroids-an in vitro kinetic study. Mol Cell Biochem, 124, 107-114.
65. Ravindran, L.N., & Stein, M.B. (2010). The pharmacologic treatment of anxiety disorders: A review of progress. Journal of Clinical Psychiatry, 71, 839-854.
66. Ritvo, E.R., Freeman, B.J., Mason-Brothers, A., Mo, A., & Ritvo, A.M. (1985). Concordance for the syndrome of autism in 40 pairs of afflicted twins. American Journal of Psychiatry, 142, 74.
67. Robinson, P., Schutz, C., Macciardi, F., White, B., & Holden, J. (2001). Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders. American Journal of Medical Genetics, 100, 30-36.
68. Roohi, J., Devincent, C.J., Hatchwell, E., & Gadow, K.D. (2009). Association of a monoamine oxidase-A gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. The Journal of Autism and Developmental Disorders, 39, 67-74.
69. Sabol, S.Z., Hu, S., & Hamer, D. (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics, 103, 273-279.
70. Samochowiec, J., Hajduk, A., Samochowiec, A., Horodnicki, J., Stepien, G., et al. (2004). Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research, 128, 21-26.
71. Shinnar, S., Rapin, I., Arnold, S., Tuchman, R.F., Shulman, L., et al. (2001). Language regression in childhood. Pediatric neurology, 24, 183-189.
72. Sparrow, S.S., Cicchetti, D.V., & Balla, D.A. (2005). Vineland Adaptive Behavior Scales, 2e. Circle Pines: AGS Publishing.
73. Steffenburg, S., Gillberg, C., Hellgren, L., Andersson, L., Gillberg, I.C., et al. (1989). A Twin Study of Autism in Denmark, Finland, Iceland, Norway and Sweden. Journal of Child Psychology and Psychiatry, 30, 405-416.
74. Sweeney, C., Wolff, R.K., Byers, T., Baumgartner, K.B., Giuliano, A.R., et al. (2007). Genetic admixture among Hispanics and candidate gene polymorphisms: Potential for confounding in a breast cancer study? Cancer Epidemiol Biomarkers Prev, 16, 142-150.
75. Todorov, C., Freeston, M., & Borgeat, F. (2000). On the pharmacotherapy of obsessive-compulsive disorder: Is a consensus possible? Canadian Journal of Psychiatry, 45, 257-262.
76. Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J.T., et al. (2009). Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 459, 528-533.
77. Wang, T.J., Huang, S.Y., Lin, W.W., Lo, H.Y., Wu, P.L., et al. (2007). Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Progress in Neuropsychopharmacology and Biololgical Psychiatry, 31, 108-114.
78. Wassink, T.H., & Piven, J. (2000). The molecular genetics of autism. Current Psychiatry Reports, 2, 170-175.
79. Williams, K., Wheeler, D.M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, 8, CD004677.
80. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of Autism in a US Metropolitan Area. Journal of the American Medical Association, 289, 49-55.
81. Yirmiya, N., Pilowsky, T., Nemanov, L., Arbelle, S., Feinsilver, T., et al. (2001). Evidence for an association with the serotonin transporter promoter region polymorphism and autism. American Journal of Medical Genetics (Neuropsychiatric Genetics), 105, 381-386.
82. Yirmiya, N., Pilowsky, T., Tidhar, S., Nemanov, L., Altmark, L., & Ebstein, R.P. (2002). Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: Possible association with IQ. American Journal of Medical Genetics, 114, 284-287.
83. Yoo, H.J., Lee, S.K., Park, M., Cho, I.H., Hyun, S.H., et al. (2009). Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neuroscience Research, 63, 172-176.
84. Zhang, Z., Jiao, Y.Y., & Sun, Q.Q. (2011). Developmental maturation of excitation and inhibition balance in principal neurons across four layers of somatosensory cortex. Neuroscience, 174, 10-25.